Trial
NCT04480450
Rituximab in Chronic Inflammatory Demyelinating Polyneuropathy
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Kansas Medical Center
Collaborators
—
Condition
Chronic Inflammatory Demyelinating Polyneuropathy
Intervention
Rituximab
Why stopped
Unable to acquire funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-09-17